Evaluation of the sensitivities of six triple-negative breast cancer (TNBC) cell lines to 23 different PI3K/AKT/mTOR inhibitors or to a MEK inhibitor (trametinib). Dataset 2 of 2: GR metrics. - Dataset (ID:20365)
Download: Excel (XLSX), Comma-separated (CSV)
Cell line | Drug name | Experimental replicate | Timepoint | Curve type (GR values) | Curve type (relative cell counts) | Experiment name | Number of concentrations | Cell doublings (DMSO control) | GR50 | GRmax | GR_AOC | GEC50 | GRinf | Hill slope (GR values) | R-squared sigmoid fit (GR values) | P-value sigmoid fit (GR values) | R-squared flat fit (GR values) | IC50 | Emax | AUC | EC50 | Einf | Hill slope (relative cell counts) | R-squared sigmoid fit (relative cell counts) | P-value sigmoid fit (relative cell counts) | R-squared flat fit (relative cell counts) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BT-549 | BX-912 | 3 | 72 | sigmoid | sigmoid | BT549 BX-912 0 3 72 | 8 | 1.728 | 1.0 | 0.335 | 0.109 | 0.758 | 0.332 | 3.91 | 0.993 | 2.87e-07 | NA | 2.46 | 0.497 | 0.916 | 0.73 | 0.496 | 3.92 | 0.992 | 6.03e-07 | NA |
BT-549 | Alpelisib | 2 | 72 | sigmoid | sigmoid | BT549 alpelisib 0 2 72 | 8 | 1.927 | Inf | 0.832 | 0.0409 | 4.24 | 0.663 | 0.548 | 0.706 | 0.0254 | NA | Inf | 0.844 | 0.962 | 4.26 | 0.686 | 0.542 | 0.696 | 0.0282 | NA |
BT-549 | CAL-101 | 1 | 72 | sigmoid | sigmoid | BT549 idelalisib 0 1 72 | 8 | 1.791 | Inf | 0.836 | 0.041 | 4.8 | 0.605 | 0.778 | 0.924 | 0.00044 | NA | Inf | 0.858 | 0.964 | 4.79 | 0.659 | 0.767 | 0.92 | 0.000518 | NA |
BT-549 | CAL-101 | 2 | 72 | sigmoid | sigmoid | BT549 idelalisib 0 2 72 | 8 | 1.975 | Inf | 0.792 | 0.0561 | 4.65 | 0.526 | 0.693 | 0.933 | 0.000307 | NA | 43.0 | 0.805 | 0.946 | 43.0 | 0.0 | 0.548 | 0.932 | 0.000314 | NA |
BT-549 | CAL-101 | 3 | 72 | sigmoid | sigmoid | BT549 idelalisib 0 3 72 | 8 | 1.770 | 43.0 | 0.79 | 0.0687 | 320.0 | -0.664 | 0.421 | 0.862 | 0.00261 | NA | 118.0 | 0.822 | 0.941 | 118.0 | 0.0 | 0.425 | 0.854 | 0.00309 | NA |
BT-549 | Everolimus | 1 | 72 | sigmoid | sigmoid | BT549 everolimus 0 1 72 | 8 | 1.772 | 5.64 | 0.503 | 0.444 | 1e-05 | 0.367 | 0.1 | 0.911 | 0.000706 | NA | 437200.0 | 0.603 | 0.641 | 0.000146 | 0.444 | 0.1 | 0.858 | 0.00286 | NA |
BT-549 | Everolimus | 3 | 72 | sigmoid | flat | BT549 everolimus 0 3 72 | 8 | 1.587 | 59.5 | 0.533 | 0.425 | 1e-05 | 0.395 | 0.1 | 0.702 | 0.0264 | NA | Inf | 0.656 | 0.685 | 0.0 | 0.656 | 0.01 | 0.48 | 0.141 | 0.685 |